SCHEMBL26851076

SCHEMBL26851076

Cc1cc2cn[nH]c2c(C(N)=O)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 6/20 0.45
▸ TNK2 Q07912 2/20 0.45
▸ LRRK2 Q5S007 2/20 0.45
▸ PLK4 O00444 1/20 0.45
▸ CHEK1 O14757 1/20 0.45
▸ AURKA O14965 1/20 0.45
▸ DAPK3 O43293 1/20 0.45
▸ MAP4K4 O95819 1/20 0.45
▸ CSF1R P07333 1/20 0.45
▸ RET P07949 1/20 0.45
▸ FGFR1 P11362 1/20 0.45
▸ PDGFRA P16234 1/20 0.45
▸ LTK P29376 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ MAP2K2 P36507 1/20 0.45
▸ FLT3 P36888 1/20 0.45
▸ CSNK1A1 P48729 1/20 0.45
▸ PRKX P51817 1/20 0.45
▸ CDK5 Q00535 1/20 0.45
▸ MAP2K1 Q02750 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29232675 0.73 BTK (0.57) BTKTNK2LRRK2PLK4CHEK1
SCHEMBL12480000 0.72 MAPT (0.41) CHEK1FGFR1PTK2MAPTHTT
SCHEMBL20674108 0.72 ADORA2A (0.38) BTKKDRLIMK1POLBHTT
SCHEMBL29494919 0.71 BTK (0.54) BTKTNK2LRRK2PLK4CHEK1
SCHEMBL29696530 0.71 CD38 (0.53) BTKTNK2LRRK2PLK4CHEK1
SCHEMBL22932817 0.70 CD38 (0.63) —
SCHEMBL12479029 0.69 NOS1 (0.41) CHEK1FGFR1PTK2MAPTHTT
SCHEMBL29949484 0.69 ALDH1A1 (0.46) BTKLCKPOLBHTTALDH1A1
SCHEMBL24949665 0.68 ALDH1A1 (0.42) BTKTNK2LRRK2PLK4CHEK1
SCHEMBL1421939 0.68 BTK (0.58) BTKTNK2LRRK2PLK4CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023217906-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-11-16 — — WO disclosed
Send feedback